Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1675461000001116 | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 1675471000001114 | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has specific active ingredient | Indacaterol acetate | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has VMP | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has dispensed dose form | Conventional release powder for inhalation | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has specific active ingredient | Mometasone furoate | true | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Indacaterol | false | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Has specific active ingredient | Indacaterol acetate | false | Inferred relationship | Existential restriction modifier | ||
| Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Atectura Breezhaler 125micrograms/62.5micrograms inhalation powder capsules with device (Sandoz Ltd) 30 capsule 3 x 10 capsules | Is a | True | Indacaterol 125micrograms/dose / Mometasone 62.5micrograms/dose inhalation powder capsules with device 30 capsule | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR